Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-028894
Filing Date
2025-06-02
Accepted
2025-06-02 19:22:07
Documents
3
Period of Report
2025-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1748906520.html 4  
1 FORM 4 wk-form4_1748906520.xml 4 6914
2 EX-24 more-form144andsection16.htm EX-24 3054
3 more-form144andsection16001.jpg GRAPHIC 189473
  Complete submission text file 0001628280-25-028894.txt   272485
Mailing Address 680 S CACHE STREET, SUITE 100 BOX 10820 JACKSON WY 83001
Business Address
MORE ROBERT J (Reporting) CIK: 0001207792 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 251016766

Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)